Celebrating our 10th anniversary – Unlock our special offer today

People vs politics – Wisconsin remains divided over what to do about cannabis

Lawmakers in the US state of Wisconsin are sympathetic to patients who could benefit from medical cannabis – but they don’t want to go against federal law.

The National Conference of State Legislatures (NCSL) places Wisconsin and its neighbour Iowa among the ten states that allow only CBD or low-THC products, as opposed to the 37 with comprehensive medical cannabis programs or legal recreational cannabis. Other states in the upper Midwest – Minnesota, North and South Dakota – have medical cannabis programs, while neighbours Michigan and Illinois have legalised recreational cannabis.

Cannabis remains a Schedule 1 controlled substance under federal law, and advocates in Wisconsin said lawmakers are hesitant to establish a state program that conflicts with that.

Read full article
I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization